med fusion, Theranostics in TheraLink assays development agreement
06:43 EDT 17 Aug 2012 | Medical Business Review
med fusion has entered into a market development agreement to validate the clinical utility of Theranostics Health's TheraLink assays for use in patients with malignant diseases.
Original Article: med fusion, Theranostics in TheraLink assays development agreement
More From BioPortfolio on "med fusion, Theranostics in TheraLink assays development agreement"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
